These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22777336)

  • 81. Impact of degenerative spinal diseases on bone mineral density of the lumbar spine in elderly women.
    Muraki S; Yamamoto S; Ishibashi H; Horiuchi T; Hosoi T; Orimo H; Nakamura K
    Osteoporos Int; 2004 Sep; 15(9):724-8. PubMed ID: 14997287
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparisons of TBS and lumbar spine BMD in the associations with vertebral fractures according to the T-scores: A cross-sectional observation.
    Lee JE; Kim KM; Kim LK; Kim KY; Oh TJ; Moon JH; Choi SH; Lim S; Kim SW; Shin CS; Jang HC
    Bone; 2017 Dec; 105():269-275. PubMed ID: 28963079
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis.
    Engelke K; Fuerst T; Dasic G; Davies RY; Genant HK
    Bone; 2010 Jun; 46(6):1626-32. PubMed ID: 20226286
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prevalence of Osteoporosis in Women in Buenos Aires Based on Bone Mineral Density at the Lumbar Spine and Femur.
    Mautalen C; Schianchi A; Sigal D; Gianetti G; Vidan V; Bagur A; González D; Mastaglia S; Oliveri B
    J Clin Densitom; 2016 Oct; 19(4):471-476. PubMed ID: 26948141
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of Speed of Sound Measures Assessed by Multisite Quantitative Ultrasound to Bone Mineral Density Measures Assessed by Dual-Energy X-Ray Absorptiometry in a Large Canadian Cohort: the Canadian Multicentre Osteoporosis Study (CaMos).
    Olszynski WP; Adachi JD; Hanley DA; Davison KS; Brown JP
    J Clin Densitom; 2016; 19(2):234-41. PubMed ID: 26050876
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bone density in proton pump inhibitors users: a prospective study.
    Ozdil K; Kahraman R; Sahin A; Calhan T; Gozden EH; Akyuz U; Erer B; Sokmen MH
    Rheumatol Int; 2013 Sep; 33(9):2255-60. PubMed ID: 23455632
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Acid-suppressive medications and risk of bone loss and fracture in older adults.
    Yu EW; Blackwell T; Ensrud KE; Hillier TA; Lane NE; Orwoll E; Bauer DC
    Calcif Tissue Int; 2008 Oct; 83(4):251-9. PubMed ID: 18813868
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A comprehensive review of treatments for postmenopausal osteoporosis.
    Häuselmann HJ; Rizzoli R
    Osteoporos Int; 2003 Jan; 14(1):2-12. PubMed ID: 12577179
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study.
    Lim Y; Jo K; Ha HS; Yim HW; Yoon KH; Lee WC; Son HY; Baek KH; Kang MI
    Osteoporos Int; 2017 Apr; 28(4):1453-1459. PubMed ID: 28083665
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
    Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
    Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A comparison between peripheral BMD and central BMD measurements in the prediction of spine fractures in men.
    Hongsdusit N; von Mühlen D; Barrett-Connor E
    Osteoporos Int; 2006; 17(6):872-7. PubMed ID: 16525761
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Poverty is a risk factor for osteoporotic fractures.
    Navarro MC; Sosa M; Saavedra P; Lainez P; Marrero M; Torres M; Medina CD
    Osteoporos Int; 2009 Mar; 20(3):393-8. PubMed ID: 18773136
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Influence on adjacent lumbar bone density after strengthening of T12, L1 segment vertebral osteoporotic compression fracture by percutaneous vertebroplasty and percutaneous kyphoplasty].
    Zhang C; Zhu K; Zhou J; Zhou X; Niu G; Wu M; Shao C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):819-23. PubMed ID: 24063170
    [TBL] [Abstract][Full Text] [Related]  

  • 97. PPI-Induced Changes in Plasma Metabolite Levels Influence Total Hip Bone Mineral Density in a UK Cohort.
    Zhang X; Adebayo AS; Wang D; Raza Y; Tomlinson M; Dooley H; Bowyer RCE; Small KS; Steves CJ; Spector TD; Duncan EL; Visconti A; Falchi M
    J Bone Miner Res; 2023 Feb; 38(2):326-334. PubMed ID: 36458982
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Long-term use of proton pump inhibitors adversely affects minerals and vitamin metabolism, bone turnover, bone mass, and bone strength.
    Hussain MS; Mazumder T
    J Basic Clin Physiol Pharmacol; 2022 Sep; 33(5):567-579. PubMed ID: 34687598
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co-administration in patients with type 2 diabetes mellitus.
    Ock M; Lee S; Kim H
    J Clin Pharm Ther; 2022 Jul; 47(7):1028-1035. PubMed ID: 35257383
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Normative bone mineral density z-scores for Canadians aged 16 to 24 years: the Canadian Multicenter Osteoporosis Study.
    Zhou W; Langsetmo L; Berger C; Adachi JD; Papaioannou A; Ioannidis G; Webber C; Atkinson SA; Olszynski WP; Brown JP; Hanley DA; Josse R; Kreiger N; Prior J; Kaiser S; Kirkland S; Goltzman D; Davison KS;
    J Clin Densitom; 2010; 13(3):267-76. PubMed ID: 20554232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.